novavax covid vaccine

Order byBest matchMost fresh

Novavax’s COVID vaccine gets FDA approval

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's Covid-19 vaccine after more than a month of delay b

· 1d · on MSN

AARP · 2d

Third COVID Vaccine Gets Approved for Adults 65 and Over

WebMD · 2d

FDA Approves Novavax COVID Vaccine With Restricted Use

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

· 1d

F.D.A. Poised to Restrict Access to Covid Vaccines

· 7h

FDA plans to limit COVID vaccine to only high-risk people: What Oklahomans should know

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 2h

· 1d

New Trump vaccine policy limits access to COVID shots

· 4h

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

3don MSN

FDA approves Novavax COVID vaccine with new conditions

President Donald Trump's tax cut and spending bill faces a critical stress test on Wednesday as Republicans in the U.S. House of Representatives try to overcome internal divisions about cuts to the Medicaid health program and tax breaks in high-cost coastal states.

3don MSN

FDA approves Novavax's COVID-19 vaccine with limitations

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.

3don MSN

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet his regulators are promising big changes that cloud the outlook for what shots might even be available.

Novavax (NasdaqGS:NVAX) Reports Q1 2025 Financial Turnaround

Novavax (NasdaqGS:NVAX) recently reported a significant financial turnaround for Q1 2025, demonstrating substantial revenue growth and net income improvements. The amending of its collaboration agreement with Takeda offers increased flexibility in vaccine development,